Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Copenhagen, Australia Clinical Trials

A listing of Copenhagen, Australia clinical trials actively recruiting patients volunteers.

RESULTS

Found (693) clinical trials

Post-Authorization Safety Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects

The purpose of the study is to acquire additional data on safety, tolerability and immunogenicity of HyQvia in pediatric (age two to <18 years) patients with Primary Immunodeficiency Diseases (PIDD)

Phase

0.47 miles

Learn More »

Danish Cardiogenic Shock Trial

Cardiogenic shock a serious complication of a heart attack (myocardial infarction). Despite rapid invasive treatment, circulatory support using positive inotropes and mechanical support with intra-aortic balloon counterpulsation (IABP), and evaluation of several new treatments during the last decade, the mortality in patients with cardiogenic shock still exceeds 50%. An alternative ...

Phase

0.47 miles

Learn More »

VitamIn and oXygen Interventions and Cardiovascular Events

Adult patients with risk factors for developing postoperative cardiac complications will be enrolled in the study. The patients will be randomised to receiving antioxidants or placebo perioperatively and 30% or 80% inspiratory oxygen concentration during anaesthesia and 2 hours postoperatively. The primary outcome is MINS (myocardial injury after non-cardiac surgery). ...

Phase

0.47 miles

Learn More »

NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation

INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in developed countries affecting approximately 30 % of the general adult population. The disease is defined by an increased fat accumulation in the liver cells (>5 %), not caused by excessive alcohol intake (a threshold ...

Phase N/A

0.47 miles

Learn More »

NAFLD Among Patients With Type 2 Diabetes and CKD

INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in developed countries affecting approximately 30 % of the general adult population. The disease is defined by an increased fat accumulation in the liver cells (>5 %), not caused by excessive alcohol intake (a threshold ...

Phase N/A

0.47 miles

Learn More »

Preparing and Timing of the Endometrium in Modified Natural Cycle Frozen-thawed Embryo Transfers

Single embryo transfer and freezing of surplus embryos has lowered twin birth rates after in vitro fertilization (IVF) to a level of less than 5% in Denmark. However, several treatments with repeated frozen embryo transfers (FET) before a viable pregnancy is confirmed are burdensome to the patients. New freezing techniques ...

Phase

0.47 miles

Learn More »

Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth

Hyposalivation and xerostomia are the most common long-term side effects to radiotherapy of head and neck cancers. A randomized clinical trial indicates that autologeous mesenchymal stem/stromal cells can restore function of the submandibular glands. Patients with previous oropharynx cancer and radiation-induced hyposalivation and xerostomia will be treated with culture expanded ...

Phase

0.47 miles

Learn More »

A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)

This is a Phase 3, randomized, double-blind, placebo-controlled, multinational, and multicenter study to evaluate the efficacy of rovalpituzumab tesirine as maintenance therapy following first-line platinum-based chemotherapy.

Phase

0.5 miles

Learn More »

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Avelumab is a human immunoglobulin (Ig)G1 monoclonal antibody (mAb) directed against programmed death ligand 1 (PD L1). Avelumab selectively binds to PD L1 and competitively blocks its interaction with programmed death receptor 1 (PD 1), thereby interfering with this key immune checkpoint inhibition pathway. Avelumab is currently being investigated as ...

Phase

0.61 miles

Learn More »

Sensory Abnormalities in Post-surgical Peripheral Neuropathy

Quantitative sensory testing (QST) is defined as perceptually quantifiable responses to graded chemical (capsaicin), electrical, mechanical (pressure, punctate, vibratory, and light touch) or thermal (cool, warmth, cold pain, and heat pain) stimuli. Thus, QST is a psychophysical method primarily assessing small nerve fiber function in the skin. The method is ...

Phase N/A

0.61 miles

Learn More »